About
Terran Biosciences develops transformative therapeutics and AI-enabled imaging software for neurological and psychiatric disorders, with a pipeline including late-stage drugs for schizophrenia and neuropsychiatric indications as well as FDA-cleared neuromelanin MRI analysis software.
Explore Terran Biosciences's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.